Cleary, J.M., Calvo, E., Moreno, V.et al.A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.Invest New Drugs38, 1483–14...